Patents by Inventor Alexander Breidenbach

Alexander Breidenbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of rotigotine for the treatment of depression
    Patent number: 8754119
    Abstract: The present invention relates to the use of rotigotine [(?)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthol] and its prodrugs and pharmaceutically acceptable salts for producing a pharmaceutical agent for treating depression.
    Type: Grant
    Filed: July 22, 2004
    Date of Patent: June 17, 2014
    Assignee: UCB Pharma GmbH
    Inventors: Dieter Scheller, Alexander Breidenbach, Norma Selve
  • Use of rotigotine for the treatment of depression
    Publication number: 20070093546
    Abstract: The present invention relates to the use of rotigotine [(?)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthol] and its prodrugs and pharmaceutically acceptable salts for producing a pharmaceutical agent for treating depression.
    Type: Application
    Filed: July 22, 2004
    Publication date: April 26, 2007
    Applicant: SRZ Properties, Inc.
    Inventors: Dieter Scheller, Alexander Breidenbach, Norma Selve
  • Substituted 2-aminotetralin for the treatment of depression
    Publication number: 20070072917
    Abstract: The invention relates to the use of a compound of general formula (I) and the pharmaceutically acceptable salts, racemates or pure enantiomers thereof for the production of a medicament used to treat depression. The substituents are defined as in the description.
    Type: Application
    Filed: July 22, 2004
    Publication date: March 29, 2007
    Applicant: SRZ Properties, Inc.
    Inventors: Dieter Scheller, Alexander Breidenbach, Norma Selve